Literature DB >> 11705106

Ibogaine in the treatment of heroin withdrawal.

D C Mash1, C A Kovera, J Pablo, R Tyndale, F R Ervin, J D Kamlet, W L Hearn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11705106     DOI： 10.1016/s0099-9598(01)56012-5

Source DB:  PubMed          Journal:  Alkaloids Chem Biol        ISSN： 1099-4831


× No keyword cloud information.
  13 in total

1.  A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification.

Authors:  Alan K Davis; Elise Renn; Austin-Marley Windham-Herman; Martin Polanco; Joseph P Barsuglia
Journal:  J Psychoactive Drugs       Date:  2018-07-18

Review 2.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 3.  Cytoplasmic permeation pathway of neurotransmitter transporters.

Authors:  Gary Rudnick
Journal:  Biochemistry       Date:  2011-08-10       Impact factor: 3.162

4.  The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women.

Authors:  Elena Argento; Melissa Braschel; Zach Walsh; M Eugenia Socias; Kate Shannon
Journal:  J Psychopharmacol       Date:  2018-09-26       Impact factor: 4.153

5.  Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.

Authors:  Thomas Knuijver; Arnt Schellekens; Maarten Belgers; Rogier Donders; Toon van Oosteren; Kees Kramers; Robbert Verkes
Journal:  Addiction       Date:  2021-08-09       Impact factor: 7.256

Review 6.  The anti-addiction drug ibogaine and the heart: a delicate relation.

Authors:  Xaver Koenig; Karlheinz Hilber
Journal:  Molecules       Date:  2015-01-29       Impact factor: 4.411

7.  Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation.

Authors:  Tamara Antonio; Steven R Childers; Richard B Rothman; Christina M Dersch; Christine King; Martin Kuehne; William G Bornmann; Amy J Eshleman; Aaron Janowsky; Eric R Simon; Maarten E A Reith; Kenneth Alper
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 8.  Ibogaine and addiction in the animal model, a systematic review and meta-analysis.

Authors:  M Belgers; M Leenaars; J R Homberg; M Ritskes-Hoitinga; A F A Schellekens; C R Hooijmans
Journal:  Transl Psychiatry       Date:  2016-05-31       Impact factor: 6.222

9.  Ligand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulations.

Authors:  Heidi Koldsø; Henriette Elisabeth Autzen; Julie Grouleff; Birgit Schiøtt
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Lena Rubi; Daniel Eckert; Stefan Boehm; Karlheinz Hilber; Xaver Koenig
Journal:  Cardiovasc Toxicol       Date:  2017-04       Impact factor: 3.231
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.